Scholarlink

Background <p>Non-adherence to antiretroviral therapy (ART) among pregnant women poses significant challenges to effective Immunodeficiency Virus (HIV) treatment outcomes and the promotion of maternal and infant health. This study identifies factors influencing ART non-adherence among HIV-positive pregnant women attending public health facilities in Dessie Town, Ethiopia.</p> Methods <p>A facility-based case–control study was conducted with 278 participants across health institutions in Dessie Town, comprising 208 controls and 70 cases. Non-adherence to ART was assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8. Data were collected through structured interviewer-administered questionnaires and by reviewing patients' medical records using pretested instruments. The collected data were coded and entered into EpiData version 4.6, then analyzed using SPSS version 25. Variables with a <i>P-</i>value of 0.2 in Bivariable analysis were included in a multivariable regression model, and Adjusted Odds Ratios (AOR) with 95% confidence intervals (CI) were calculated. <i>P-</i>values less than 0.05 were considered statistically significant.</p> Results <p>In total, 208 controls and 70 cases were included in the study. Significant factors determining non-adherence to ART among HIV-positive pregnant women included forgetfulness to take ART (AOR = 2.414, 95% CI = 1.067–5.464, <i>P</i> = 0.034), non-disclosure (AOR = 2.955, 95% CI = 1.431–6.103, <i>P</i> = 0.003), an unplanned pregnancy (AOR = 3.045, 95% CI = 1.439–6.445, <i>P</i> = 0.004), those who did not participate in mother-support groups (AOR = 3.278, 95% CI = 1.611–6.672, <i>P</i> = 0.001), World Health Organization (WHO) clinical stages III &amp; IV (AOR = 2.669, 95% CI = 1.279–5.569, <i>P</i> = 0.009), and those who did not take opportunistic infection prophylaxis (AOR = 3.873, 95% CI = 1.549–9.688, <i>P</i> = 0.004).</p> Conclusions <p>Key determinants included forgetfulness, non-disclosure of HIV status, unplanned pregnancies, lack of participation in mother-support groups, advanced WHO clinical stages (III &amp; IV), and non-use of opportunistic infection prophylaxis.</p> Recommendations <p>All relevant parties, including front-line healthcare professionals, should advise women to use family planning more frequently to reduce unintended pregnancies. They should also encourage health education regarding disclosing HIV status to her spouse and ensure that all pregnant women are provided with opportunistic infection prophylaxis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Determinants of non-adherence to antiretroviral therapy among seropositive pregnant women at public health facilities in Dessie Town, Ethiopia, 2024

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月3日

查看全文
  • Moges Sisay Chekole,
  • Alemtsehay Wossen Samuel,
  • Amare Workie Gashu,
  • Negesse Belayneh Gessesse,
  • Birhan Tsegaw Taye,
  • Tebabere Moltot Kitaw,
  • Mulualem Silesh Zerihun,
  • Tesfanesh Lemma Demssie,
  • Tirusew Nigussie Kebede,
  • Desta Mekete Kibret,
  • Toyba Ebrahim Yesuf,
  • Kidist Ayalew Abebe,
  • Mekuanint Terefe Kassa,
  • Legesse Demissie Worknew

摘要

Background

Non-adherence to antiretroviral therapy (ART) among pregnant women poses significant challenges to effective Immunodeficiency Virus (HIV) treatment outcomes and the promotion of maternal and infant health. This study identifies factors influencing ART non-adherence among HIV-positive pregnant women attending public health facilities in Dessie Town, Ethiopia.

Methods

A facility-based case–control study was conducted with 278 participants across health institutions in Dessie Town, comprising 208 controls and 70 cases. Non-adherence to ART was assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8. Data were collected through structured interviewer-administered questionnaires and by reviewing patients' medical records using pretested instruments. The collected data were coded and entered into EpiData version 4.6, then analyzed using SPSS version 25. Variables with a P-value of 0.2 in Bivariable analysis were included in a multivariable regression model, and Adjusted Odds Ratios (AOR) with 95% confidence intervals (CI) were calculated. P-values less than 0.05 were considered statistically significant.

Results

In total, 208 controls and 70 cases were included in the study. Significant factors determining non-adherence to ART among HIV-positive pregnant women included forgetfulness to take ART (AOR = 2.414, 95% CI = 1.067–5.464, P = 0.034), non-disclosure (AOR = 2.955, 95% CI = 1.431–6.103, P = 0.003), an unplanned pregnancy (AOR = 3.045, 95% CI = 1.439–6.445, P = 0.004), those who did not participate in mother-support groups (AOR = 3.278, 95% CI = 1.611–6.672, P = 0.001), World Health Organization (WHO) clinical stages III & IV (AOR = 2.669, 95% CI = 1.279–5.569, P = 0.009), and those who did not take opportunistic infection prophylaxis (AOR = 3.873, 95% CI = 1.549–9.688, P = 0.004).

Conclusions

Key determinants included forgetfulness, non-disclosure of HIV status, unplanned pregnancies, lack of participation in mother-support groups, advanced WHO clinical stages (III & IV), and non-use of opportunistic infection prophylaxis.

Recommendations

All relevant parties, including front-line healthcare professionals, should advise women to use family planning more frequently to reduce unintended pregnancies. They should also encourage health education regarding disclosing HIV status to her spouse and ensure that all pregnant women are provided with opportunistic infection prophylaxis.